Dislocation Rates of Primary Total Hip Arthroplasty in Patients With Prior Lumbar Spine Fusion and Lumbar Degenerative Disk Disease With and Without Utilization of Dual Mobility Cups: An American Joint Replacement Registry Study.

Joseph M Nessler, Arthur L Malkani, Patrick J Yep, Kyle J Mullen,Richard L Illgen

The Journal of the American Academy of Orthopaedic Surgeons(2022)

引用 1|浏览2
暂无评分
摘要
INTRODUCTION:Patients undergoing primary total hip arthroplasty (THA) with a previous history of lumbar spine fusion (LSF) are at increased risk of dislocation. The purpose of this study was to compare the 90-day and 1-year dislocation rates of patients with LSF or lumbar degenerative disk disease who underwent primary THA with and without dual mobility (DM) constructs. METHODS:An American Joint Replacement Registry data set of patients aged 65 years and older undergoing primary THA with minimum 1-year follow-up with a history of prior LSF or a diagnosis of lumbar degenerative disk disease was created. DM status was identified, and dislocation and all-cause revision at 90 days and 1 year were assessed. RESULTS:A total of 15,572 patients met study criteria. The overall dislocation rates for the non-DM and DM groups were 1.17% and 0.68%, respectively, at 90 days, and 1.68% and 0.91%, respectively, at 1 year ( P = 0.005). The odds of 90-day (OR = 0.578, [ P = 0.0328]) and 1-year (OR = 0.534, [ P = 0.0044]) dislocation were significantly less with DM constructs, compared with non-DM constructs. No statistically significant difference was observed in revision rates between groups. DISCUSSION:This large registry-based study identified a reduced risk of dislocation in patients at risk for spinal stiffness when a DM compared with non-DM construct was used in primary THA at 90-day and 1-year follow-up intervals. Our data support the use of DM constructs in high-risk patients with stiff spines and altered spinopelvic mobility as a promising option to mitigate the risk of postoperative hip instability after primary THA. LEVELS OF EVIDENCE:Level III. Therapeutic retrospective cohort.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要